Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-20-000919
Filing Date
2020-11-24
Accepted
2020-11-24 16:24:26
Documents
1
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_6919.html 4  
1 PRIMARY DOCUMENT doc4_6919.xml 4 12293
  Complete submission text file 0001638599-20-000919.txt   13692
Mailing Address C/O INVESTOR GROWTH CAPITAL, INC. 630 FIFTH AVENUE, SUITE 1965 NEW YORK NY 10011
Business Address
LaBelle Curt H (Reporting) CIK: 0001396235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 201344475

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations